e.g. mhealth
Search Results (1 to 10 of 10 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 3 JMIR Public Health and Surveillance
- 3 Journal of Medical Internet Research
- 2 JMIR Formative Research
- 1 JMIR Research Protocols
- 1 Journal of Participatory Medicine
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
This study also identified two significant risk factors for HCV infection: having a family member positive for HCV and the use of intravenous medication in the past 5 years [10]. These efforts underscore the complexity of the hepatitis epidemic in Cambodia and the multifaceted approach required to address it.
JMIR Res Protoc 2024;13:e63376
Download Citation: END BibTex RIS
Existing literature available for HCV education is focused on the comanagement of opioid use disorders and do not provide targeted information on general HCV treatment and cure [17-19]. In response to these gaps as well as needs assessment and feedback from multidisciplinary stakeholders, we developed an app to address the lack of HCV educational resources available to patients and health care supportive staff. The app guides the user through the HCV treatment stages in a self-exploratory way.
JMIR Form Res 2024;8:e52729
Download Citation: END BibTex RIS
Additionally, people with OUD have high hepatitis C virus (HCV) incidence and prevalence due to injection drug use and limited access to HCV therapy [3]. To achieve HCV elimination by 2030, as proposed in several jurisdictions [4-6], HCV treatment access must increase.
We sought to address restricted HCV care access for people with OUD through a randomized controlled trial of care integration using technology that is at the intersection of the internet or videoconferencing, and health care.
J Med Internet Res 2024;26:e53049
Download Citation: END BibTex RIS
Hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis infection are also all major public health problems worldwide. HBV, HCV, and syphilis are the 3 most common infections among people living with HIV/AIDS all over the world and share similar transmission routes [2,3]. The burden of HBV, HCV, and syphilis infection in people living with HIV/AIDS is even larger than in the general population. The ever-increasing burden of these infections has become a growing concern [4].
JMIR Public Health Surveill 2024;10:e46750
Download Citation: END BibTex RIS
However, there is a lack of information about HCV testing behavior and willingness to undergo HCV screening in the general Chinese population.
This study was conducted to assess HCV knowledge, self-reported HCV testing behavior, and willingness to undergo HCV screening in the general Chinese population to inform policy decision-making aimed at eliminating HCV. The characteristics of patients who have less knowledge and are less likely to undergo testing were also explored.
JMIR Public Health Surveill 2023;9:e39472
Download Citation: END BibTex RIS
HCV can be transmitted during pregnancy or delivery—an estimated 5.8% of infants born to women with HCV infection become infected [4]. Perinatal infection can result in liver disease during adulthood and sequelae such as cirrhosis and hepatocellular carcinoma [5]. The incidence of acute HCV infection in the United States increased annually from 2009 to 2019, with rates highest among adults 20-29 and 30-39 years of age, including women of childbearing age [6,7].
JMIR Public Health Surveill 2023;9:e40783
Download Citation: END BibTex RIS
Infections such as hepatitis C (HCV) and HIV disproportionally affect people who inject drugs. Globally, over half of people who inject drugs are infected with HCV, and nearly 1 in 5 with HIV [1-5]. Many people who inject drugs are unaware of their HCV or HIV status, and rates of accessing treatment are low. For instance, fewer than 10% of those infected with HCV receive treatment [6], increasing morbidity and contributing to ongoing virus spread [7].
J Particip Med 2023;15:e47395
Download Citation: END BibTex RIS
Hepatitis C virus (HCV) is highly prevalent among people who inject drugs [1-5]. The advent of direct-acting antivirals has the potential to halt the HCV epidemic and dramatically reduce the public health burden of the disease. Yet, despite the availability of these new highly efficacious regimens, HCV treatment uptake in this group has been limited by barriers at the individual, health system, social, and economic levels [1,6-8].
J Med Internet Res 2023;25:e38176
Download Citation: END BibTex RIS
Hepatitis C virus (HCV) infection is a major public health problem: An estimated 71 million people worldwide are living with chronic HCV infection, which, if left untreated, may progress to serious liver disease [1]. In 2016, approximately 399,000 people died from HCV-related cirrhosis and liver cancer, and the number of deaths increases each year [2].
JMIR Form Res 2020;4(9):e19100
Download Citation: END BibTex RIS
The World Health Organization estimated that in 2015, 71 million people worldwide were living with chronic hepatitis C virus (HCV) infection. Although recent studies report that the incidence of HCV has decreased during the past 50 years [1-3], estimates obtained from modeling suggest that in 2015, there were still 1.75 million new HCV infections worldwide—a global incidence rate of 23.7 per 100,000 [4].
J Med Internet Res 2020;22(4):e15532
Download Citation: END BibTex RIS